Your session is about to expire
← Back to Search
Practice Facilitation for Unhealthy Alcohol Use
N/A
Waitlist Available
Led By Emily C. Williams, PhD MPH
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18 years and older.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3- and 6-months post implementation intervention
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether practice facilitation can help improve the quality of care for those with unhealthy alcohol use.
Who is the study for?
This trial is for Veterans aged 18 or older who are receiving care at a VA primary care site where the study is being conducted. It's specifically for those with unhealthy alcohol use and includes primary care staff involved in screening, as well as providers practicing at the clinic regularly.
What is being tested?
The study tests an implementation strategy called practice facilitation to see if it can improve how primary care handles unhealthy alcohol use. The goal is to see if this approach helps providers offer better substance use care, like more effective counseling and increased referrals to specialty clinics.
What are the potential side effects?
Since this intervention involves implementing a new practice method rather than a medical treatment, traditional side effects associated with medications are not applicable here.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3- and 6-months post implementation intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3- and 6-months post implementation intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Adoption of alcohol related care via self-report change
Adoption of alcohol-related care via electronic health record change
Maintenance of alcohol-related care via electronic health record
+1 moreSecondary study objectives
Clinical Effectiveness via electronic health record
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Practice facilitation implementation interventionExperimental Treatment1 Intervention
6 months during which practice facilitation is implemented to support the primary care clinic in improving routine, population-based screening, assessment, treatment, and follow-up for unhealthy alcohol use and AUDs.
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,746 Total Patients Enrolled
43 Trials studying Alcoholism
6,053 Patients Enrolled for Alcoholism
Emily C. Williams, PhD MPHPrincipal InvestigatorVA Puget Sound Health Care System Seattle Division, Seattle, WA
Rachel L. Bachrach, PhD MSPrincipal InvestigatorVA Ann Arbor Healthcare System, Ann Arbor, MI
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I am a primary care provider who screens for alcohol use and works at the clinic weekly.You are a veteran receiving care at a VA primary care site during the pilot testing of a new healthcare intervention.
Research Study Groups:
This trial has the following groups:- Group 1: Practice facilitation implementation intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger